Search Login Register

Type 5 Cyclic Nucleotide Phosphodiesterases Summary

307 relevant articles (43 outcomes, 31 trials/studies) found for this Bio-Agent

Description: A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC GMP. It is found predominantly in vascular tissue and plays an important role in regulating VASCULAR SMOOTH MUSCLE contraction.

Also Known As: Cyclic Nucleotide Phosphodiesterases, Type 5; PDE5 Phosphodiesterases; Phosphodiesterase 5; Phosphodiesterase V; Phosphodiesterase-5 Show All >>

Key Diseases for which Type 5 Cyclic Nucleotide Phosphodiesterases is Relevant

  1. Erectile Dysfunction : 25 outcomes 9 studies in 144 results
  2. Hypertension (High Blood Pressure) : 7 outcomes 5 studies in 37 results
  3. Cardiovascular Diseases (Cardiovascular Disease) : 3 outcomes in 7 results
  4. Pulmonary Hypertension (Ayerza Syndrome) : 2 outcomes 5 studies in 41 results
  5. Heart Failure : 2 outcomes 1 study in 10 results
Show All >>

Drugs Related to Type 5 Cyclic Nucleotide Phosphodiesterases

  1. sildenafil (Viagra)
  2. tadalafil (Cialis)
  3. vardenafil (Levitra)
  4. 5'-Guanylic Acid (GMP)
  5. Endothelin Receptors (Endothelin Receptor)
  6. DA 8159 (udenafil)
  7. Nitric Oxide (Nitrogen Monoxide)
  8. Prostaglandins
  9. Nitrates
  10. Natriuretic Peptides
Show All >>

Therapies Related to Type 5 Cyclic Nucleotide Phosphodiesterases

  1. Prostatectomy (Retropubic Prostatectomy)
  2. Lung Transplantation
  3. Balloon Angioplasty (Angioplasty, Transluminal)
  4. Drug Therapy (Chemotherapy)
  5. Withholding Treatment
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.